Functional heterologous protein expression by genetically engineered probiotic yeast Saccharomyces boulardii

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Hudson, Lauren E ^a   Fasken, Milo B ^a   McDermott, Courtney D ^a   McBride, Shonna M ^a   Kuiper, Emily G ^a   Guiliano, David B ^b   Corbett, Anita H ^a   Lamb, Tracey J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF EAST LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; FUNGAL PROTEIN; PLASMID VECTOR; PROBIOTIC AGENT; PROTEIN URA3; RECOMBINANT PROTEIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG; URACIL;

AMINO ACID SUBSTITUTION; ANAEROBIC GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUXOTROPHIC MUTANT; CELL SURVIVAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; DRUG UPTAKE; FEMALE; FUNGAL STRAIN; FUNGUS GROWTH; FUNGUS ISOLATION; FUNGUS MUTANT; GASTROINTESTINAL TRACT; GENETIC ENGINEERING; HETEROLOGOUS EXPRESSION; IN VITRO STUDY; MOUSE; MOUSE MODEL; NONHUMAN; OPEN READING FRAME; PEYER PATCH; PH; PHYSICAL RESISTANCE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RADIATION MUTAGENESIS; SACCHAROMYCES BOULARDII; SURVIVAL RATE; ULTRAVIOLET IRRADIATION; WILD TYPE; ANIMAL; DRUG EFFECTS; GENETICS; METABOLISM; MICROBIOLOGY; SACCHAROMYCES;

SACCHAROMYCES BOULARDII;

ANIMALS; GASTROINTESTINAL TRACT; MICE; PROBIOTICS; RECOMBINANT PROTEINS; SACCHAROMYCES;

EID: 84911499717     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112660     Document Type: Article

References (39)

1. Dujon B (1996) The yeast genome project: what did we learn? Trends Genet 12: 263-270. Available: http://www.ncbi.nlm.nih.gov/pubmed/8763498.
2. Edwards-Ingram LC, Gent ME, Hoyle DC, Hayes A, Stateva LI, et al. (2004) Comparative Genomic Hybridization Provides New Insights Into the Molecular Taxonomy of the Saccharomyces Sensu Stricto Complex. Genome Res: 1043- 1051. doi:10.1101/gr.2114704
3. Kurugöl Z, Koturoglu G (2005) Effects of Saccharomyces boulardii in children with acute diarrhoea. Acta Paediatr 94: 44-47. Available: http://doi.wiley.com/ 10.1080/08035250410022521.
4. McFarland LV (2010) Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol 16: 2202. Available: http:// www.wjgnet.com/1007-9327/full/v16/i18/2202.htm.
5. Di Giacinto C, Marinaro M, Sanchez M, Strober W, Boirivant M (2005) Probiotics Ameliorate Recurrent Th1-Mediated Murine Colitis by Inducing IL-10 and IL-10-Dependent TGF- -Bearing Regulatory Cells. J Immunol 174: 3237-3246. Available: http://www.jimmunol.org/cgi/doi/10.4049/jimmunol. 174.6.3237.
6. Martins FS, Silva AA, Vieira AT, Barbosa FHF, Arantes RME, et al. (2009) Comparative study of Bifidobacterium animalis, Escherichia coli, Lactobacillus casei and Saccharomyces boulardii probiotic properties. Arch Microbiol 191: 623-630. Available: http://www.ncbi.nlm.nih.gov/pubmed/19526225.
7. Generoso SV, Viana ML, Santos RG, Arantes RME, Martins FS, et al. (2011) Protection against increased intestinal permeability and bacterial translocation induced by intestinal obstruction in mice treated with viable and heat-killed Saccharomyces boulardii. Eur J Nutr 50: 261-269. Available: http://www.ncbi. nlm.nih.gov/pubmed/20936479.
8. Dahan S, Dalmasso G, Imbert V, Peyron J, Rampal P, et al. (2003) Saccharomyces boulardii Interferes with Enterohemorrhagic Escherichia coli - Induced Signaling Pathways in T84 Cells. Infect Immun 71: 766-773. doi:10.1128/IAI.71.2.766
9. Martins FS, Vieira AT, Elian SDA, Arantes RME, Tiago FCP, et al. (2013) Inhibition of tissue inflammation and bacterial translocation as ones of the protective mechanisms of Saccharomyces boulardii against Salmonella infection in mice. Microbes Infect: 1-10. Available: http://www.ncbi.nlm.nih.gov/ pubmed/23376166.
10. Czerucka D, Roux I, Rampal P (1994) Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3 9,59-cyclic monophosphate induction in intestinal cells. Gastroenterology 106: 65-72.
11. Castagliuolo I, Mont JTLA, Nikulasson ST (1996) Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat Saccharomyces boulardii Protease Inhibits Clostridium difficile Toxin A Effects in the Rat Ileum. 64.
12. Demain AL, Vaishnav P (2009) Production of recombinant proteins by microbes and higher organisms. Biotechnol Adv 27: 297-306. Available: http://www. ncbi.nlm.nih.gov/pubmed/19500547.
13. Edwards-Ingram L, Gitsham P, Burton N, Warhurst G, Clarke I, et al. (2007) Genotypic and physiological characterization of Saccharomyces boulardii, the probiotic strain of Saccharomyces cerevisiae. Appl Environ Microbiol 73: 2458-2467. Available: http://www.pubmedcentral.nih.gov/articlerender. fcgi?artid=1855594&tool=pmcentrez&rendertype=abstract.
14. Fietto JLR, Arau?jo RS, Valada?o FN, Fietto LG, Branda?o RL, et al. (2004) Molecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardii. Can J Microbiol 50: 615-621. Available: http:// www.ncbi.nlm.nih.gov/pubmed/15467787.
15. Berg R, Bernasconi P, Fowler D, Gautreaux M (1993) Inhibition of Candida albicans translocation from the gastrointestinal tract of mice by oral administration of Saccharomyces boulardii. J Infect Dis 168: 1314-1318. Available: http://www.ncbi.nlm.nih.gov/pubmed/8228371.
16. Blehaut H, Massot J, Elmer G, Levy R (1989) Disposition kinetics of Saccharomyces boulardii in man and rat. Biopharm Drug Dispos 10: 353-364.
17. Mcfarland LV, Bernasconi P (1993) Saccharomyces boulardii: A Review of an Innovative Biotherapeutic Agent. Micorbial Ecol Heal Dis 6: 157-171.
18. Boddy AV, Elmer GW, Mcfarland LV, Levy RH (1991) Influence of Antibiotics on the Recovery and Kinetics of S boulardii in Rats. Pharm Res 8.
19. Latorre-Garća L, Adam AC, Polaina J (2008) Overexpression of the glucoamylase-encoding STA1 gene of Saccharomyces cerevisiae var. diastaticus in laboratory and industrial strains of Saccharomyces. World J Microbiol Biotechnol 24: 2957-2963. Available: http://link.springer.com/10.1007/ s11274-008-9837-9.
20. Douradinha B, Reis VCB, Rogers MB, Torres FAG, Evans JD, et al. (2014) Novel insights in genetic transformation of the probiotic yeast Saccharomyces boulardii. Bioengineered 5: 1-9.
21. Michael S, Keubler LM, Smoczek A, Meier M, Gunzer F, et al. (2012) Quantitative phenotyping of inflammatory bowel disease in the IL-10-deficient mouse by use of noninvasive magnetic resonance imaging. Inflamm Bowel Dis 19: 185-193. Available: http://www.ncbi.nlm.nih.gov/pubmed/22570250.
22. Hamedi H, Misaghi A, Modarressi MH, Salehi TZ, Khorasanizadeh D, et al. (2013) Generation of a Uracil Auxotroph Strain of the Probiotic Yeast Saccharomyces boulardii as a Host for the Recombinant Protein Production. Avicenna J Med Biotechnol 5: 29-34.
23. Wang T, Sun H, Zhang J, Liu Q, Wang L, et al. (2013) The establishment of Saccharomyces boulardii surface display system using a single expression vector. Fungal Genet Biol: 1-10. Available: http://www.ncbi.nlm.nih.gov/pubmed/ 24309301.
24. Burke D, Dawson D, Stearns T (2000) Methods in yeast genetics: a Cold Spring Harbor Laboratory course manual. Cold Spring Harbor Lab Press.
25. rd ed. Cold Spring Harbor, NY: Cold Spring Harbor Lab Press.
26. Sikorski RS, Hieter P (1989) A System of Shuttle Vectors and Yeast Host Strains Designed for Efficient Manipulation of DNA in. Genetics 122: 19-27.
27. Degtyareva NP, Chen L, Mieczkowski P, Petes TD, Doetsch PW (2008) Chronic oxidative DNA damage due to DNA repair defects causes chromosomal instability in Saccharomyces cerevisiae. Mol Cell Biol 28: 5432-5445. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2519736&tool=pm centrez&rendertype=abstract.
28. Dimitrov LN, Brem RB, Kruglyak L, Gottschling DE (2009) Polymorphisms in multiple genes contribute to the spontaneous mitochondrial genome instability of Saccharomyces cerevisiae S288C strains. Genetics 183: 365-383. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2746160&tool=pm centrez&rendertype=abstract.
29. Tran HT, Keen JD, Kricker M, Resnick MA, Gordenin DA, et al. (1997) Hypermutability of homonucleotide runs in mismatch repair and DNA polymerase proofreading yeast mutants. Mol Cell Biol 17.
30. Boeke JD, LaCroute F, Fink GR (1984) A positive selection for mutants lacking orotidine- 59-phosphate decarboxylase activity in yeast 5-fluoro-orotic acid resistance. Mol Gen Genet 197: 345-346.
31. Boeke JD, Trueheart J, Natsoulis G, Fink GR (1987) 5-Fluoroorotic Acid as a Selective Agent in Yeast Molecular Genetics. Methods Enzymol 154: 164-175.
32. Edwards AN, Sua?rez JM, McBride SM (2013) Culturing and maintaining Clostridium difficile in an anaerobic environment. J Vis Exp: e50787. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3871928&tool=pm centrez&rendertype=abstract.
33. Benatuil L, Perez JM, Belk J, Hsieh CM (2010) An improved yeast transformation method for the generation of very large human antibody libraries. Protein Eng Des Sel 23: 155-159. Available: http://www.ncbi.nlm. nih.gov/pubmed/20130105.
34. Lehr R (1992) Sixteen S-squared over D-squared: a relation for crude sample size estimates. Stat Med 11: 1099-1102. Available: http://www.ncbi.nlm.nih. gov/pubmed/1496197.
35. Hashimoto S, Ogura M, Aritomi K, Hoshida H, Nishizawa Y, et al. (2005) Isolation of Auxotrophic Mutants of Diploid Industrial Yeast Strains after UV Mutagenesis. Appl Environ Microbiol: 312-319. doi:10.1128/AEM.71.1.312
36. Miller BG, Hassell AM, Wolfenden R, Milburn MV, Short SA (2000) Anatomy of a proficient enzyme: the structure of orotidine 59-monophosphate decarboxylase in the presence and absence of a potential transition state analog. Proc Natl Acad Sci U S A 97: 2011-2016. Available: http://www.pubmedcentral.nih. gov/articlerender.fcgi?artid=15745&tool=pmcentrez&rendertype=abstract.
37. Rose M, Grisafi P, Botstein D (1984) Sturcture and function of the yeast URA3 gene: expression in Escherichia coli. Gene 29: 113-124.
38. Schulz O, Pabst O (2012) Antigen sampling in the small intestine. Trends Immunol: 1-7. Available: http://www.ncbi.nlm.nih.gov/pubmed/23083727.
39. Van der Aa Ku?hle A, Skovgaard K, Jespersen L (2005) In vitro screening of probiotic properties of Saccharomyces cerevisiae var. boulardii and food-borne Saccharomyces cerevisiae strains. Int J Food Microbiol 101: 29-39. Available: http://www.ncbi.nlm.nih.gov/pubmed/15878404.